USA flag logo/image

An Official Website of the United States Government

Bioimpedance Control of Ultrafiltration on Hemodialysis

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
29393
Program Year/Program:
1995 / SBIR
Agency Tracking Number:
29393
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
HEMOCLEANSE, INC.
3601 SAGAMORE PARKWAY N, STE B LAFAYETTE, IN 47904
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 1995
Title: Bioimpedance Control of Ultrafiltration on Hemodialysis
Agency: HHS
Contract: 1 R43 DK49892-01,
Award Amount: $100,000.00
 

Abstract:

We will apply thoracic electric bioimpedance monitoring by external electrodes (TEB) to those patieunstable on hemodialysis and find a primary cardiovascular parameter which predicts the onset of symOur expectation is that percent fall in cardiac output will be the primary indicator, but we will alcardiovascular parameters, machine-generated ultrafiltration data, and SO2 and hematocrit (by Crit-Lthat there are no better predictors of symptomatic hypotension. We will define a "stop-UF" algorithmultrafiltration rate before symptomatic hypotension and clinically test this in Phase II. Also in Phclinically test a "dry weight" algorithm which monitors cardiovascular parameters and receives usersymptoms and clinical findings to automatically determine dry weight of all hemodialysis patients.

Principal Investigator:

Stephen Ash
31763

Business Contact:

Small Business Information at Submission:

Hemocleanse, Inc.
2701-B Kent Avenue West Lafayette, IN 47906

EIN/Tax ID:
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No